Literature DB >> 12131466

Isolated unilateral adduction deficit and ptosis as the presenting features of chronic inflammatory demyelinating polyradiculoneuropathy.

Christina Pieh1, Beatrice Rossillion, Anne C Heritier-Barras, Michel Chofflon, Theodor Landis, Avinoam B Safran.   

Abstract

A patient with chronic inflammatory demyelinating polyneuropathy (CIDP) presented with an isolated unilateral adduction deficit and ptosis. Investigations were negative until the onset of limb weakness and fatigue 2 years later. At that time, electroneuromyography, cerebrospinal fluid examination, and magnetic resonance imaging confirmed the diagnosis of CIDP. Thus, ophthalmic signs can precede extremity and bulbar signs with a long latency in CIDP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12131466     DOI: 10.1097/00041327-200206000-00005

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  5 in total

Review 1.  From ophthalmoplegic migraine to cranial neuropathy.

Authors:  Stefanie Förderreuther; Ruth Ruscheweyh
Journal:  Curr Pain Headache Rep       Date:  2015-06

2.  Neuro-ophthalmological Complications of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Authors:  S J Hickman; J A Allen; A Baisre; R Batty; H B Lari; O Melen; I M Pepper; P G Sarrigiannis; R E Turbin; S B Wharton; C J McDermott
Journal:  Neuroophthalmology       Date:  2013-07-25

3.  Long-Lasting Cranial Nerve III Palsy as a Presenting Feature of Chronic Inflammatory Demyelinating Polyneuropathy.

Authors:  Rossella Spataro; Vincenzo La Bella
Journal:  Case Rep Med       Date:  2015-04-16

4.  A case of chronic inflammatory demyelinating polyneuropathy presented with unilateral ptosis.

Authors:  Sadegh Izadi; Sina Karamimagham; Maryam Poursadeghfard
Journal:  Med J Islam Repub Iran       Date:  2014-05-10

5.  A Case of Relapsing - Remitting CIDP with Sixth Nerve Palsy.

Authors:  Arikrishnan Thelengana; Vinay Goyal
Journal:  Ann Indian Acad Neurol       Date:  2021-10-11       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.